← Open Payments lookup

DANIELLE GIPSON: Open Payments

NPI 1518447911 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,524 in 132 payments from 11 companies in 2025. Trend: 2023 $1,150 · 2024 $963 · 2025 $2,524

Food & beverage: $2,412Education: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.34$544
Neurocrine BioSciences, Inc.16$425
Otsuka America Pharmaceutical, Inc.16$283
Teva Pharmaceuticals USA, Inc.15$278
Janssen Pharmaceuticals, Inc11$239
Axsome Therapeutics, Inc.6$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$190
Alkermes, Inc.9$156
Vanda Pharmaceuticals Inc.4$85
ABBVIE INC.4$71

Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, Auvelity, CAPLYTA, ABILIFY MAINTENA, ARISTADA, REXULTI.

Industry payments across TX — which companies pay providers there.